According to the latest report by IMARC Group, titled “Pediatric Interventional Cardiology Market Report: Global Industry Trends, Size, Share, Growth, Opportunity and Forecast 2022-2027,” offers a comprehensive analysis of the industry, which comprises insights on the global pediatric interventional cardiology market. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The global pediatric interventional cardiology market reached a value of US$ 2.28 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 3.46 Billion by 2027, exhibiting a CAGR of 6.80% during 2022-2027.
Pediatric Interventional Cardiology Market Overview :
Infants, kids, and teenagers up to age 18 can have heart conditions treated using particular catheter-based procedures in paediatric interventional cardiology. It covers a variety of operations, including coronary thrombectomy, angioplasty, the correction of congenital cardiac defects, and catheter-based valve implantation. When compared to traditional cardiological therapies, paediatric interventional cardiology techniques are less invasive, which lowers the risk of problems following surgery. They are therefore widely used in many areas of the healthcare industry, such as clinical testing laboratories, hospitals, cardiac centres, paediatric clinics, research institutes, etc.
Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/pediatric–interventional–cardiology–market/requestsample
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Pediatric Interventional Cardiology Market Trends and Drivers:
The growing instances of numerous congenital cardiac diseases among children, such as atrioventricular canal defect, Patent Ductus Arteriosus (PDA), Ventricular Septal Defect (VSD) Atrial septal defect (ASD), etc., are primarily driving the pediatric interventional cardiology market.
Additionally, the development of novel and highly efficient devices, including guidewires, balloons, stents, vascular closure instruments, catheters, bioabsorbable stents, etc., is also positively influencing the market growth.
Besides this, the shifting preference toward non-invasive medical treatment approaches, owing to their associated benefits, such as shorter postoperative recovery times, lower risk of infection, avoidance of large scars, etc., is acting as another significant growth-inducing factor.
Moreover, the inflating healthcare expenditures undertaken by the government bodies across the developing countries and the launch of extensive research and development (R&D) activities by key market players aimed at achieving substantial technological advancements in the field of cardiology are anticipated to catalyze the pediatric interventional cardiology market over the forecasted period.
|Pediatric Interventional Cardiology Market Report Scope|
|Market size value in 2021||US$ 2.28 Billion|
|Market forecast in 2027||US$ 3.46 Billion|
|Growth Rate||CAGR of 6.80% from 2022 to 2027|
|Base year for estimation||2021|
Global Pediatric Interventional Cardiology Market 2022–2027 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Biotronik SE & Co. KG, Boston Scientific Corporation, Cardinal Health Inc., Edwards Lifesciences Corporation, General Electric Company, Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co. Ltd., Medtronic plc, NuMED Inc., Siemens Healthineers AG, Terumo Corporation and W. L. Gore & Associates Inc.
Inquire Before Buying : https://www.imarcgroup.com/request?type=report&id=5043&flag=F
The report has segmented the market on the basis of region, device type, procedure and end use.
Breakup by Device Type:
- Closure Devices
- Transcatheter Heart Valves
- Atherectomy Devices
Breakup by Procedure:
- Catheter-Based Valve Implantation
- Congenital Heart Defect Correction
- Coronary Thrombectomy
Market Breakup by End Use:
- Clinical Testing Laboratories
- Cardiac Centers
- Pediatric Clinics
- Research Institutions
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=5043&flag=C
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.